What are the implications of missing the nuchal translucency (NT) scan?

Apr 26, 2022 Source: Cainiu Health
Dr. Wang Huiying
Introduction
NT refers to the nuchal translucency thickness—the fluid-filled space at the back of the fetal neck—primarily used to assess the risk of Down syndrome. Missing the NT scan during pregnancy generally has no major consequences; however, performing it during early pregnancy is preferable. The NT scan is not a mandatory component of routine prenatal care for all women. Currently, numerous clinical screening methods for Down syndrome are available, including maternal serum screening (triple or quadruple test), four-dimensional (4D) ultrasound, and non-invasive prenatal testing (NIPT) using cell-free fetal DNA.

       NT (nuchal translucency) screening measures the thickness of the fluid-filled space at the back of the fetal neck. Its primary purpose is to assess the risk of Down syndrome (trisomy 21). Missing the NT scan during pregnancy generally has no major adverse consequences, although performing it during early pregnancy is optimal. Details are as follows:

       If the NT scan is missed, alternative prenatal screening tests can be performed. The NT scan is a critical examination conducted between 11 and 14 weeks of gestation. Scans performed before 11 weeks or after 14 weeks may yield inaccurate results; therefore, missing the window beyond 14 weeks means the opportunity for NT screening has been lost. The NT scan uses ultrasound to precisely measure the nuchal translucency thickness, thereby aiding in the assessment of fetal risk for Down syndrome. However, an abnormal NT measurement does not constitute a definitive diagnosis of Down syndrome; further diagnostic testing—such as amniocentesis—is required to confirm the diagnosis.

       In fact, NT screening is not a mandatory component of routine prenatal care. Clinically, multiple screening methods for Down syndrome are available today. If the NT scan is missed between weeks 11 and 14, it is recommended to undergo maternal serum screening (commonly known as “triple” or “quadruple” test) between weeks 15 and 20, or a detailed anatomical survey using 4D ultrasound between weeks 22 and 28. When clinically indicated, non-invasive prenatal testing (NIPT) may also be considered. These alternatives can help determine whether the fetus is affected by Down syndrome or other structural anomalies.